From: A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment
Patient
DC injections
Regular (boosting)
Best response (duration)
1
4
PDa
2
PD
3
5
4(2)
SDb (105Â days)
6
7
8
9
10
11
12
4(1)
SD (98Â days)